The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Male Infertility Treatment Market Research Report 2024

Global Male Infertility Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885491

No of Pages : 91

Synopsis
Male infertility treatment includes medical interventions and therapies aimed at addressing fertility issues in men, such as sperm quality, quantity, and motility problems.
The global Male Infertility Treatment market was valued at US$ 1303.8 million in 2023 and is anticipated to reach US$ 2229.8 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The market for male infertility treatment is driven by factors such as the increasing prevalence of male infertility and the growing awareness about fertility treatments for men. The market's growth is also influenced by ongoing research and development in reproductive medicine.
This report aims to provide a comprehensive presentation of the global market for Male Infertility Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Male Infertility Treatment.
Report Scope
The Male Infertility Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Male Infertility Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Male Infertility Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions
Livzon Pharmaceutical Group Inc.
Zhejiang Xianju Pharmaceutical Co.,Ltd.
GeneScience Pharmaceuticals Co., Ltd.
Abeona Therapeutics Inc.
ASKA Pharmaceutical Co., Ltd.
Bristol Myers Squibb
Church & Dwight
Intas Biopharmaceuticals
Eli Lilly and Company
Segment by Type
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Male Infertility Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Male Infertility Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Fragmentation Technique
1.2.3 Oxidative Stress Analysis
1.2.4 Microscopic Examination
1.2.5 Sperm Agglutination
1.2.6 Computer Assisted Semen Analysis
1.2.7 Sperm Penetration Assay
1.3 Market by Application
1.3.1 Global Male Infertility Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Male Infertility Treatment Market Perspective (2019-2030)
2.2 Male Infertility Treatment Growth Trends by Region
2.2.1 Global Male Infertility Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Male Infertility Treatment Historic Market Size by Region (2019-2024)
2.2.3 Male Infertility Treatment Forecasted Market Size by Region (2025-2030)
2.3 Male Infertility Treatment Market Dynamics
2.3.1 Male Infertility Treatment Industry Trends
2.3.2 Male Infertility Treatment Market Drivers
2.3.3 Male Infertility Treatment Market Challenges
2.3.4 Male Infertility Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Male Infertility Treatment Players by Revenue
3.1.1 Global Top Male Infertility Treatment Players by Revenue (2019-2024)
3.1.2 Global Male Infertility Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Male Infertility Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Male Infertility Treatment Revenue
3.4 Global Male Infertility Treatment Market Concentration Ratio
3.4.1 Global Male Infertility Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Male Infertility Treatment Revenue in 2023
3.5 Male Infertility Treatment Key Players Head office and Area Served
3.6 Key Players Male Infertility Treatment Product Solution and Service
3.7 Date of Enter into Male Infertility Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Male Infertility Treatment Breakdown Data by Type
4.1 Global Male Infertility Treatment Historic Market Size by Type (2019-2024)
4.2 Global Male Infertility Treatment Forecasted Market Size by Type (2025-2030)
5 Male Infertility Treatment Breakdown Data by Application
5.1 Global Male Infertility Treatment Historic Market Size by Application (2019-2024)
5.2 Global Male Infertility Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Male Infertility Treatment Market Size (2019-2030)
6.2 North America Male Infertility Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Male Infertility Treatment Market Size by Country (2019-2024)
6.4 North America Male Infertility Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Male Infertility Treatment Market Size (2019-2030)
7.2 Europe Male Infertility Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Male Infertility Treatment Market Size by Country (2019-2024)
7.4 Europe Male Infertility Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Male Infertility Treatment Market Size (2019-2030)
8.2 Asia-Pacific Male Infertility Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Male Infertility Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Male Infertility Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Male Infertility Treatment Market Size (2019-2030)
9.2 Latin America Male Infertility Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Male Infertility Treatment Market Size by Country (2019-2024)
9.4 Latin America Male Infertility Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Male Infertility Treatment Market Size (2019-2030)
10.2 Middle East & Africa Male Infertility Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Male Infertility Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Male Infertility Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Serono
11.1.1 Merck Serono Company Detail
11.1.2 Merck Serono Business Overview
11.1.3 Merck Serono Male Infertility Treatment Introduction
11.1.4 Merck Serono Revenue in Male Infertility Treatment Business (2019-2024)
11.1.5 Merck Serono Recent Development
11.2 Aytu BioScience
11.2.1 Aytu BioScience Company Detail
11.2.2 Aytu BioScience Business Overview
11.2.3 Aytu BioScience Male Infertility Treatment Introduction
11.2.4 Aytu BioScience Revenue in Male Infertility Treatment Business (2019-2024)
11.2.5 Aytu BioScience Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Male Infertility Treatment Introduction
11.3.4 Bayer Revenue in Male Infertility Treatment Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Cadila
11.4.1 Cadila Company Detail
11.4.2 Cadila Business Overview
11.4.3 Cadila Male Infertility Treatment Introduction
11.4.4 Cadila Revenue in Male Infertility Treatment Business (2019-2024)
11.4.5 Cadila Recent Development
11.5 Intas Pharma
11.5.1 Intas Pharma Company Detail
11.5.2 Intas Pharma Business Overview
11.5.3 Intas Pharma Male Infertility Treatment Introduction
11.5.4 Intas Pharma Revenue in Male Infertility Treatment Business (2019-2024)
11.5.5 Intas Pharma Recent Development
11.6 Halotech DNA
11.6.1 Halotech DNA Company Detail
11.6.2 Halotech DNA Business Overview
11.6.3 Halotech DNA Male Infertility Treatment Introduction
11.6.4 Halotech DNA Revenue in Male Infertility Treatment Business (2019-2024)
11.6.5 Halotech DNA Recent Development
11.7 SCSA diagnostics
11.7.1 SCSA diagnostics Company Detail
11.7.2 SCSA diagnostics Business Overview
11.7.3 SCSA diagnostics Male Infertility Treatment Introduction
11.7.4 SCSA diagnostics Revenue in Male Infertility Treatment Business (2019-2024)
11.7.5 SCSA diagnostics Recent Development
11.8 Andrology Solutions
11.8.1 Andrology Solutions Company Detail
11.8.2 Andrology Solutions Business Overview
11.8.3 Andrology Solutions Male Infertility Treatment Introduction
11.8.4 Andrology Solutions Revenue in Male Infertility Treatment Business (2019-2024)
11.8.5 Andrology Solutions Recent Development
11.9 Livzon Pharmaceutical Group Inc.
11.9.1 Livzon Pharmaceutical Group Inc. Company Detail
11.9.2 Livzon Pharmaceutical Group Inc. Business Overview
11.9.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Introduction
11.9.4 Livzon Pharmaceutical Group Inc. Revenue in Male Infertility Treatment Business (2019-2024)
11.9.5 Livzon Pharmaceutical Group Inc. Recent Development
11.10 Zhejiang Xianju Pharmaceutical Co.,Ltd.
11.10.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Detail
11.10.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
11.10.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Introduction
11.10.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Revenue in Male Infertility Treatment Business (2019-2024)
11.10.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Development
11.11 GeneScience Pharmaceuticals Co., Ltd.
11.11.1 GeneScience Pharmaceuticals Co., Ltd. Company Detail
11.11.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
11.11.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Introduction
11.11.4 GeneScience Pharmaceuticals Co., Ltd. Revenue in Male Infertility Treatment Business (2019-2024)
11.11.5 GeneScience Pharmaceuticals Co., Ltd. Recent Development
11.12 Abeona Therapeutics Inc.
11.12.1 Abeona Therapeutics Inc. Company Detail
11.12.2 Abeona Therapeutics Inc. Business Overview
11.12.3 Abeona Therapeutics Inc. Male Infertility Treatment Introduction
11.12.4 Abeona Therapeutics Inc. Revenue in Male Infertility Treatment Business (2019-2024)
11.12.5 Abeona Therapeutics Inc. Recent Development
11.13 ASKA Pharmaceutical Co., Ltd.
11.13.1 ASKA Pharmaceutical Co., Ltd. Company Detail
11.13.2 ASKA Pharmaceutical Co., Ltd. Business Overview
11.13.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Introduction
11.13.4 ASKA Pharmaceutical Co., Ltd. Revenue in Male Infertility Treatment Business (2019-2024)
11.13.5 ASKA Pharmaceutical Co., Ltd. Recent Development
11.14 Bristol Myers Squibb
11.14.1 Bristol Myers Squibb Company Detail
11.14.2 Bristol Myers Squibb Business Overview
11.14.3 Bristol Myers Squibb Male Infertility Treatment Introduction
11.14.4 Bristol Myers Squibb Revenue in Male Infertility Treatment Business (2019-2024)
11.14.5 Bristol Myers Squibb Recent Development
11.15 Church & Dwight
11.15.1 Church & Dwight Company Detail
11.15.2 Church & Dwight Business Overview
11.15.3 Church & Dwight Male Infertility Treatment Introduction
11.15.4 Church & Dwight Revenue in Male Infertility Treatment Business (2019-2024)
11.15.5 Church & Dwight Recent Development
11.16 Intas Biopharmaceuticals
11.16.1 Intas Biopharmaceuticals Company Detail
11.16.2 Intas Biopharmaceuticals Business Overview
11.16.3 Intas Biopharmaceuticals Male Infertility Treatment Introduction
11.16.4 Intas Biopharmaceuticals Revenue in Male Infertility Treatment Business (2019-2024)
11.16.5 Intas Biopharmaceuticals Recent Development
11.17 Eli Lilly and Company
11.17.1 Eli Lilly and Company Company Detail
11.17.2 Eli Lilly and Company Business Overview
11.17.3 Eli Lilly and Company Male Infertility Treatment Introduction
11.17.4 Eli Lilly and Company Revenue in Male Infertility Treatment Business (2019-2024)
11.17.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’